Home › Cancro del polmone non a piccole cellule › Wisconsin › La Crosse
Studi clinici su Cancro del polmone non a piccole cellule a La Crosse, WI
10 studi su Cancro del polmone non a piccole cellule cercano partecipanti presso sedi a La Crosse e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
In reclutamentoFase 3
- Gundersen Lutheran Medical Center, La Crosse
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
In reclutamentoFase 3
- Gundersen Lutheran Medical Center, La Crosse
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
In reclutamentoFase 2
- Gundersen Lutheran Medical Center, La Crosse
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
In reclutamentoFase 2/3
- Gundersen Lutheran Medical Center, La Crosse
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
In reclutamentoFase 2
- Gundersen Lutheran Medical Center, La Crosse
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
In reclutamentoFase 2
- Gundersen Lutheran Medical Center, La Crosse
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
In reclutamentoFase 2/3
- Gundersen Lutheran Medical Center, La Crosse
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
In reclutamentoFase 2
- Gundersen Lutheran Medical Center, La Crosse
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
In reclutamentoStudio osservazionale
- Gundersen Lutheran Medical Center, La Crosse
- Mayo Clinic Health System-Franciscan Healthcare, La Crosse
GEMINI-NSCLC: NSCLC Biomarker Study
In reclutamentoStudio osservazionale
- Gundersen Health System, La Crosse
Studi su Cancro del polmone non a piccole cellule in altre città
- Houston, TX145 studi
- New York City, NY121 studi
- Arlington, VA104 studi
- Nashville, TN97 studi
- Boston, MA90 studi
- Los Angeles, CA87 studi
- St. Louis, MO73 studi
- Chicago, IL61 studi
- Baltimore, MD60 studi
- San Antonio, TX59 studi
- Columbus, OH57 studi
- Washington, DC55 studi
Altri studi a La Crosse
- Cancro ai polmoni9 studi
- Cancro al seno6 studi
- Leucemia mieloide acuta6 studi
- Mieloma multiplo4 studi
- Linfoma diffuso a grandi cellule B3 studi
- Cancro della laringe3 studi
- Cancro orale3 studi
- Carcinoma a cellule squamose della testa e del collo3 studi
- Cancro dell'endometrio3 studi
- Cancro ovarico3 studi
- Melanoma3 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.